“They sure are in a big hurry to get these new mRNA shots into as many as possible before midterms but why the rush. What other ingredients are in these shots they so desperately want in everyone.” Admin
Doctors and the media are questioning the U.S. Food and Drug Administration (FDA) over its recent decision to approve the all-new “bivalent” booster shots for the Wuhan coronavirus (Covid-19), which have never been tested on humans.
The argument goes that the new shots vary so little from the older ones that they do not need to undergo any human clinical trials. This is the FDA’s argument after it rubber-stamped the latest injections at warp speed.
FDA Commissioner Robert Califf and Center for Biologics Evaluation and Research Director Peter Marks indicated that the federal agency used the same process for approving the new boosters that it uses to approve new annual flu shots.
“This is the number one question people are asking,” Califf said in a press conference.
Marks added that the FDA has “extensive experience in the past with strain changes made without clinical data based on the totality of available evidence.” (Related: Moderna’s own internal data shows that the shots are not effective against the Moronic subvariant of Chinese Germs.)
Independent media barred from asking questions during FDA virtual press conference
Read More: FDA approves Omicron “booster” jab before midterms without a single human test – NaturalNews.com
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr